Sagittal Abdominal Diameter as a Screening Tool in Clinical Research: Cutoffs for Cardiometabolic Risk

Table 1

Individual anthropometric measures and cardiometabolic risk factors divided into quintiles in men.

	Quintile 1	Quintile 2	Quintile 3	Quintile 4	Quintile 5
SAD (cm)	$18.1\pm 2.1$	$18.8\pm 2.2$	$19.4\pm 2.3$	$20.5\pm 2.6$	$22.0\pm 3.0$
Waist (cm)	$79.0\pm 8.7$	$82.5\pm 9.0$	$85.0\pm 10.4$	$89.8\pm 10.9$	$95.7\pm 12.4$
Waist-to-hip ratio	$0.8\pm 0.05$	$0.81\pm 0.05$	$0.82\pm 0.05$	$0.85\pm 0.06$	$0.88\pm 0.06$
BMI	$24.2\pm 3.5$	$25.3\pm 3.6$	$26.1\pm 4.0$	$7.7\pm 4.5$	$29.8\pm 5.0$
Glucose (mmol/L)*	$4.7\pm 0.4$	$4.9\pm 0.5$	$5.2\pm 0.8$	$5.5\pm 1.3$	$6.2\pm 2.3$
Insulin (mU/L)*	$6.1\pm 4.0$	$7.5\pm 3.1$	$9.4\pm 5.2$	$10.6\pm 5.1$	$14.5\pm 7.9$
Triglycerides (mmol/L)*	$0.8\pm 0.2$	$1.0\pm 0.4$	$1.1\pm 0.5$	$1.4\pm 0.6$	$1.9\pm 0.9$
LDL cholesterol (mmol/L)*	$3.7\pm 0.9$	$3.8\pm 0.9$	$3.9\pm 1.0$	$4.0\pm 0.9$	$4.1\pm 1.0$
HDL cholesterol (mmol/L)*	$1.9\pm 0.3$	$1.7\pm 0.4$	$1.7\pm 0.4$	$1.5\pm 0.4$	$1.4\pm 0.3$
ApoB/ApoA1	$0.56\pm \mathrm{\hspace{0.17em}\hspace{0.17em}}0.1$	$0.61\pm 0.2$	$0.66\pm 0.2$	$0.71\pm 0.2$	$0.81\pm 0.2$
Systolic BP (mm Hg)*	$114\pm 11$	$124\pm 15$	$136\pm 19$	$142\pm 20$	$153\pm 20$
Diastolic BP (mm Hg)*	$72\pm 6$	$77\pm 7$	$82\pm 9$	$85\pm 9$	$89\pm 9$
Fibrinogen (g/L)	$2.7\pm 0.6$	$2.9\pm 0.7$	$3.1\pm 0.7$	$3.2\pm 0.8$	$3.4\pm 0.8$
γ-Glutamyltransferase ($\mu$kat/L)	$0.39\pm 0.7$	$0.40\pm 0.3$	$0.48\pm 0.6$	$0.7\pm 0.9$	$0.7\pm 1.0$

Data are Mean ± SD. ${}^{*}$Risk factors included in the cardiometabolic risk score.